Aster DM Healthcare DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.66×	0.70×	11.04×	0.78×	0.89×
	0.80×	0.95×	0.95×	0.76×	0.68×
	14.1%	13.7%	12.5%	9.7%	6.6%
	0.63×	0.63×	0.34×	0.23×	0.87×
	1.68×	1.68×	1.81×	3.58×	3.06×
	7.9%	9.7%	80.4%	4.7%	10.6%
	9.7%	9.7%	134.7%	2.9%	10.1%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ASTERDM₹679.20

Aster DM Healthcare Ltd.

· Pharma & Health

₹ CrorePeersAPOLLOHOSP MAXHEALTH KIMS COHANCE WOCKPHARMA SYNGENE GLAND LALPATHLABMcap ₹35,191 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.89	0.78	11.04	0.70	0.66
Interest Burden (Pretax/EBIT) ×	0.68	0.76	0.95	0.95	0.80
EBIT Margin %	6.58	9.68	12.46	13.71	14.10
Asset Turnover ×	0.87	0.23	0.34	0.63	0.63
Financial Leverage (Assets/Equity) ×	3.06	3.58	1.81	1.68	1.68
ROE (5-step product, year-end total equity) %	10.61	4.71	80.38	9.73	7.87
ROE (owners' profit / average owners' equity) %	10.12	2.87	134.65	9.70	9.70

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.